Endogenous extracellular purine nucleotides redirect alpha2-adrenoceptor signaling

FEBS Lett. 1998 Jul 3;430(3):209-12. doi: 10.1016/s0014-5793(98)00664-4.

Abstract

Many receptors coupled to inhibitory Go/Gi-type G proteins often also produce stimulatory signals like Ca2+ mobilisation. When expressed in CHO cells the alpha2-adrenoceptor subtypes alpha2A, alpha2B and alpkha2C mobilised Ca2+. These responses were strongly reduced by the P2Y-purinoceptor antagonist suramin. A large proportion of the total pool of purine nucleotides was found extracellularly. Removal of extracellular nucleotides with apyrase or by constant perfusion had a similar effect as suramin. These treatments did not affect the alpha2-adrenoceptor-mediated inhibition of cAMP production. This indicates that cells may be primed or their signaling pathways redirected towards Ca2+ mobilisation by 'autocrine' release of nucleotides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology*
  • Adenosine Triphosphate / physiology
  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Apyrase / pharmacology
  • CHO Cells
  • Calcium / metabolism*
  • Calcium-Transporting ATPases / antagonists & inhibitors
  • Cricetinae
  • Cyclic AMP / metabolism
  • Enzyme Inhibitors / pharmacology
  • Norepinephrine / pharmacology
  • Purinergic P2 Receptor Antagonists
  • Receptors, Adrenergic, alpha-2 / physiology*
  • Signal Transduction / physiology*
  • Suramin / pharmacology
  • Thapsigargin / pharmacology

Substances

  • Adrenergic alpha-Agonists
  • Enzyme Inhibitors
  • Purinergic P2 Receptor Antagonists
  • Receptors, Adrenergic, alpha-2
  • Suramin
  • Thapsigargin
  • Adenosine Triphosphate
  • Cyclic AMP
  • Apyrase
  • Calcium-Transporting ATPases
  • Calcium
  • Norepinephrine